Charcot Foot Reconstruction Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Global Charcot Foot Reconstruction Market is segmented By Disease Type (Type 1 (Midfoot) Arthropathy , Type 2 (Hindfoot) Arthropathy , Type 3A (Ankle) Arthropathy , Type 3B (Calcaneus) Arthropathy), By Device Type (Fusion Bolts, External Fixation Systems, Foot Plating Systems, Bone Screws, Others), By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others), and By Region (North America, Europe, South America, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2024-2031

Charcot Foot Reconstruction Market Overview

Global Charcot foot reconstruction market reached US$ YY million in 2023 and is expected to reach US$ YY million by 2031, growing at a CAGR of YY% during the forecast period 2024-2031.

Charcot foot is a rare complication of diabetes-related neuropathy. It can make injuries or infections much more serious. Charcot foot is also known as Charcot arthropathy or Charcot neuroarthropathy. This condition is the result of undetected injuries to the bones of the foot, which can lead to significant deformity and disability. Surgical reconstruction of the Charcot foot has been proposed as a method to preserve the foot.

Midfoot is the most commonly affected region in Charcot neuroarthropathy of the foot. Charcot reconstruction is the surgical procedure of repairing and restoring the foot. Charcot reconstruction is performed under general anesthesia and may include cutting and realignment of the foot and ankle bones and fusion. Reconstructive surgery of the Charcot foot typically entails stabilization and arthrodesis of multiple collapsed joints. Plantar exostectomy, plastic coverage and posterior muscle group lengthening are often performed concomitantly with various types of reconstruction devices.

Charcot Foot Reconstruction Market Scope

For more details on this report - Request for Sample

Charcot Foot Reconstruction Market Dynamics

Rising demand for advanced reconstruction devices 

The rising demand for advanced reconstruction devices is expected to drive the market over the forecast period. The rising prevalence in diabetes cases and associated complications, including neuropathy leading to Charcot Foot syndrome, has contributed to an increased demand for advanced charcot reconstruction devices. Charcot foot is rare and affects less than 1% of all people with diabetes.

There is a growing preference for reconstruction devices that show better results for Charcot foot reconstruction. There are various types of advanced devices are used for the reconstruction process like external and internal fixation devices, foot plating systems, bone screws and intramedullary nailing systems among others. These advanced devices helps in better fixation.

For instance, in September 2020, Stryker launched its T2 ICF intramedullary nailing system. The new system is meant to help people suffering from serious foot conditions including Charcot foot, which can arise among people with diabetes and cause poor bone quality and potential nerve damage and foot ulcers. 

The T2 ICF system is a stable product that provides a surgical option designed to prevent nail backout and promote fixation and accuracy. It is estimated that a leg is amputated every 30 seconds globally, and 85% of these amputations are the result of diabetic foot ulcers.

These advanced reconstruction devices are focussing on developing patient-specific devices. The Charcot foot reconstruction market could benefit from patient-specific device design. Devices can be custom-designed to fit each patient's unique anatomy using modern imaging techniques and 3D printing technologies. 

This personalized method has the potential to improve device fit, biomechanics and patient outcomes. Improved deformity repair and joint function are also possible with patient-specific device design. Thus, there is an increasing demand for advanced reconstruction devices globally.

Further, the increasing prevalence of Charcot foot reconstruction, increasing awareness about the reconstruction devices and rising advancements in the development of novel reconstruction devices with more advanced features are the factors expected to drive the market over the forecast period.

Market Restraints

Factors such as complications associated with the reconstruction surgery like hardware failure, deep and superficial infection, wound dehiscence, pseudoarthrosis, instability and amputation, the high cost of the reconstruction devices, unmet needs and uncertainties regarding reconstruction surgeries are the factors expected to hamper the market. 

Charcot Foot Reconstruction Market Segmentation

The global charcot foot reconstruction market is segmented based on disease type, device type, end-user and region.

The foot plating systems segment accounted for approximately 57.6% of the Charcot foot reconstruction market share

The foot plating systems segment is expected to hold the largest market share over the forecast period. Charcot foot often involves severe bone deformities and fractures. Foot plating systems provide a means to stabilize and align the bones properly during surgical reconstruction. This stability is crucial for the healing process and preventing further deformities.

For instance, in October 2020, Extremity Medical released its AXIS Charcot Plate System. The AXIS Charcot Plate System is reported to be the only FDA-cleared fixation platform that offers tension-side plantar plate options specifically for Charcot foot deformity. The Axis system also features proprietary Advanced Fixation “Compression Post” Technology designed to amplify compression and increase stability, even in poor bone quality.

Foot plating systems offer a range of plate sizes and designs, allowing surgeons to select the most appropriate fixation for the specific anatomy and pathology of the patient. This versatility is important in addressing the diverse nature of Charcot foot deformities. The foot has a complex anatomy with various joints and structures. Foot plating systems are designed to adapt to the anatomical contours of the foot, providing a more precise and tailored fit. This helps in achieving better stability and alignment during reconstruction.

For instance, in July 2022, Paragon 28, Inc. launched its Gorilla Central Column Plating System, offering plates and instrumentation that may be used in isolation for acute or chronic midfoot application or in cases of Charcot. The system consists of 16 plates which are optimized to fit the bony anatomy of the midfoot and address conditions of TN and/or NC joint. 

The system provides 1.5- and 2.0 mm thick (Charcot) plates in talus to metatarsal and navicular to metatarsal spanning options. Surgeons may compress the plates using the Caspar which is available in the Gorilla instrument tray or use the plates to span the fracture site. A novel Rasp is included to aid in the preparation of the joint surfaces. The addition of the Gorilla Central Column Plating System increases the number of plating options within the Gorilla Plating System to 309 plates making it the most robust reconstruction and trauma foot and ankle offering on the market.

Charcot foot patients often experience altered weight distribution and increased pressure on certain areas of the foot. Foot plating systems can provide load-bearing support, redistributing forces and preventing excessive stress on vulnerable areas. Foot plating systems are designed to minimize soft tissue disruption during surgery. This is important in Charcot foot cases, where patients may already have compromised soft tissue integrity.

Charcot Foot Reconstruction Market Geographical Share

North America accounted for approximately 42.6% of the market share 

North America region is expected to hold the largest market share over the forecast period owing to the strong presence of major players and increasing advancements. North America especially the United States is very well known for its strong presence of major players which actively focus on the development of advanced devices for the Charcot foot reconstruction.

For instance, in December 2020, MedShape, Inc. announced the full market release of the DynaNail Mini Fusion System for medial column fusion to Charcot Foot and other severe midfoot conditions. Featuring MedShape's patented superelastic nickel-titanium (NiTiNOL) technology, the DynaNail Mini is the first internal fixation device designed specifically for medial column fusion that offers maintained active compression post-surgery to promote bone healing and joint stability.

Approximately 1,530,000 people are diagnosed with diabetes in the United States each year. Diabetics face serious complications to the foot and ankle, including nerve damage and poor circulation that can weaken the bones, resulting in conditions such as Charcot arthropathy (Charcot Foot and Charcot Ankle). Out of the 29 million people suffering from diabetes, around 0.08-0.13% develop Charcot Foot or Charcot Ankle. This painless, progressive, inflammatory, destructive degenerative disease can cause severe deformity, joint dislocations and fractures.

The United States boasts advanced healthcare infrastructure, including state-of-the-art hospitals, research institutions and medical facilities. This infrastructure facilitates the adoption of the latest technologies and advancements in medical devices. These more advanced devices for the Charcot foot reconstruction showed better results in the patients. These devices such as fusion bolts, external fixation systems, foot-plating systems, bone screws, nailing systems and others helps in better Charcot foot reconstruction. 

Charcot Foot Reconstruction Market Companies

The major global players in the Charcot foot reconstruction market include DePuy Synthes, Wright Medical Group N.V., Acumed LLC, Integra LifeSciences Corporation, Orthofix US LLC, Arthrex, Inc., DJO, LLC, BioPro, Inc., Össur and Stryker Corporation among others. 

COVID-19 Impact Analysis

The COVID-19 pandemic has had widespread effects on healthcare systems, including its impact on the Charcot foot reconstruction market. Since the development and progression of Charcot’s neuroarthropathy is closely linked with various inflammatory pathways, a bidirectional relationship with COVID-19 infection may exist as well.

The cancellation of most outpatient clinical services has posed a potential threat to those with diabetic foot problems including active diabetic foot ulcers (DFUs), significant ischemia and Charcot neuroarthropathy. Hospitals and healthcare facilities initially focused on managing and treating COVID-19 cases, leading to a prioritization of essential healthcare services. Non-urgent orthopedic procedures might have been deprioritized during certain periods.

Why Purchase the Report?

• To visualize the global Charcot foot reconstruction market segmentation based on disease type, device type, end-user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development
• Excel data sheet with numerous data points of Charcot foot reconstruction market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global Charcot foot reconstruction market report would provide approximately 61 tables, 61 figures and 187 Pages.

Target Audience 2024

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies